Amy P. Abernethy

2001–2024 年に発表

128
論文数
27,814
被引用数
93
h 指数
126
i10 指数

被引用数

Amy P. Abernethy の年別被引用数1996 年: 被引用 1 件2001 年: 被引用 3 件2002 年: 被引用 5 件2003 年: 被引用 19 件2004 年: 被引用 12 件2005 年: 被引用 21 件2006 年: 被引用 19 件2007 年: 被引用 35 件2008 年: 被引用 57 件2009 年: 被引用 41 件2010 年: 被引用 61 件2011 年: 被引用 75 件2012 年: 被引用 132 件2013 年: 被引用 192 件2014 年: 被引用 280 件2015 年: 被引用 330 件2016 年: 被引用 327 件2017 年: 被引用 356 件2018 年: 被引用 289 件2019 年: 被引用 1,240 件2020 年: 被引用 1,212 件2021 年: 被引用 955 件2022 年: 被引用 706 件2023 年: 被引用 407 件2024 年: 被引用 811 件2025 年: 被引用 314 件2026 年: 被引用 25 件1997〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,552 件、この内訳の 33.4%イギリス: 引用元論文 949 件、この内訳の 8.9%オーストラリア: 引用元論文 611 件、この内訳の 5.7%カナダ: 引用元論文 582 件、この内訳の 5.5%イタリア: 引用元論文 416 件、この内訳の 3.9%オランダ: 引用元論文 408 件、この内訳の 3.8%中国: 引用元論文 400 件、この内訳の 3.8%ドイツ: 引用元論文 396 件、この内訳の 3.7%フランス: 引用元論文 292 件、この内訳の 2.8%日本: 引用元論文 221 件、この内訳の 2.1%スイス: 引用元論文 217 件、この内訳の 2%スペイン: 引用元論文 217 件、この内訳の 2%
0%33.4%その他 22.4%

分野

  • Medicine68%
  • Health Professions9.9%
  • Economics, Econometrics and Finance7.3%
  • Biochemistry, Genetics and Molecular Biology3.9%
  • Psychology2.9%
  • Social Sciences1.7%
  • その他6.3%

トピック

  • Palliative Care and End-of-Life Issues7.1%
  • Cancer survivorship and care6.5%
  • Economic and Financial Impacts of Cancer3.2%
  • Childhood Cancer Survivors' Quality of Life2.6%
  • Health Systems, Economic Evaluations, Quality of Life2.4%
  • Mobile Health and mHealth Applications2.3%
  • その他75.9%

共著者

全論文

検索で開く
  1. The Promise of Digital Health: Then, Now, and the Future

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul C. Tang, Eric J. Topol, Reed V. Tuckson, Kristen Valdes, b.well Connected Health - NAM Perspectives 2022 被引用: 440

  2. Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2014 被引用: 1,127

  3. Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2019 被引用: 565

  4. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials

    著者: , , , , , , - The Lancet Oncology 2016 被引用: 628

  5. The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience

    著者: , , , , , , - The Oncologist 2013 被引用: 1,102

  6. Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2015 被引用: 1,015

  7. Generalist plus Specialist Palliative Care — Creating a More Sustainable Model

    著者: , - New England Journal of Medicine 2013 被引用: 1,445

  8. Financial toxicity, Part I: a new name for a growing problem.

    著者: , - 2013 被引用: 500

  9. Mobile Health Technology Evaluation

    著者: , , , , , , , , , , , , , , , , , , - American Journal of Preventive Medicine 2013 被引用: 943

  10. Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Internal Medicine 2015 被引用: 496

  11. Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint

    著者: , , , , , , , , , , - Health Services Research 2018 被引用: 221

  12. The Integration of Clinical Trials With the Practice of Medicine

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven R. Cummings, Gregory Curfman, Laura J. Esserman, Lee A. Fleisher, Joseph B. Franklin, Ralph Gonzalez, Cynthia Grossman, Tufia C. Haddad, Roy S. Herbst, Adrian F. Hernandez, Diane Holder, Leora Horn, Grant D. Huang, Alison J. Huang, Nancy Kass, Rohan Khera, Walter J. Koroshetz, Harlan M. Krumholz, Martin Landray, Roger Lewis, Tracy A. Lieu, Preeti Malani, Christa Lese Martin, Mark McClellan, Mary Mcdermott, Stephanie R. Morain, Susan A. Murphy, Stuart G. Nicholls, Stephen J. Nicholls, Peter J. O’Dwyer, Bhakti K. Patel, Eric C. Peterson, Sheila A. Prindiville, Joseph S. Ross, Kathy Rowan, Gordon D. Rubenfeld, Christopher Seymour, Rod S Taylor, Joanne Waldstreicher, Tracy Y. Wang - JAMA 2024 被引用: 70

  13. The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]

    著者: , , , , - BMC Palliative Care 2005 被引用: 529

  14. American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care

    著者: , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 1,332

  15. Diversity, Equity, and Inclusion in Clinical Research: A Path Toward Precision Health for Everyone

    著者: , , , , - Clinical Pharmacology & Therapeutics 2022 被引用: 60

  16. Patient-reported outcomes in cancer care — hearing the patient voice at greater volume

    著者: , - Nature Reviews Clinical Oncology 2017 被引用: 255

  17. Patient-Oncologist Cost Communication, Financial Distress, and Medication Adherence

    著者: , , , , , , , , , , , , - Journal of Oncology Practice 2014 被引用: 257

  18. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia

    著者: , , , , , - Annals of Oncology 2017 被引用: 179

  19. Real‐world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non–small cell lung cancer

    著者: , , , , , , , , , , , , - Cancer 2019 被引用: 138

  20. Review of Electronic Patient-Reported Outcomes Systems Used in Cancer Clinical Care

    著者: , , , , , , , - Journal of Oncology Practice 2014 被引用: 312

  21. The Burden of Polypharmacy in Patients Near the End of Life

    著者: , , , , - Journal of Pain and Symptom Management 2015 被引用: 143

  22. Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set

    著者: , , , , , , , , , , , , - JCO Clinical Cancer Informatics 2019 被引用: 107

  23. Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non–Small Cell Lung Cancer in the Community Oncology Setting

    著者: , , , , , , , , , , , , - JAMA 2018 被引用: 135

  24. An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , - JCO Clinical Cancer Informatics 2019 被引用: 134